Clinical staging of ketamine-associated urinary dysfunction: a strategy for assessment and treatment
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Purpose To describe a clinical staging method linked to stepwise treatment indications for ketamine-associated urinary dysfunction (KAUD) based on review of our experience in management of KAUD patients and analysis of their clinical features.Methods The eighty-one KAUD patients hospitalized from January 2008 to June 2014 were studied retrospectively. According to ketamine history, renal and liver function, bladder change and up urinary tract involvement, patients were categorized into a described model of three stages. Discriminant analysis was applied to validate the model. The void volume, micturition interval, nocturnal void frequency and pelvic pain and urgency/frequency (PUF) questionnaire score were, respectively, compared after treatments.Results There were, respectively, 24, 47 and 10 patients in three stages. The duration of abuse varied (p = 0.047) correlated with clinical stages (p = 0.015, r = 0.268). The severity of LUTS was not significant. The creatinine, estimated glomerular filtration rate and liver function were worse in higher stages (p < 0.01), and the incidence of ureteral change and hydronephrosis was greater (p < 0.001). Based on the model, cross-validation confirmed 83.1 % cases were classified correctly. Twenty-four patients in stage I were treated with behavioral modification and pharmacotherapy, thirty-five patients in stage II with hydrodistention and six patients in stage III with surgical intervention due to rapid progression after conservative therapy. All patients in three stages demonstrated improvements in void volume, micturition interval, nocturnal void frequency and PUF score (all p < 0.05) after treatment.Conclusion Clinical staging could serve for assessment of progression, and the staging-based treatment is effective. This model still awaits further validation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Currently used in some countries to treat narcolepsy and alcohol withdrawal, gamma-hydroxybutyric acid (GHB; 'liquid Ecstasy') intake is associated with both increased central Dopamine levels and activation of GABA-A/B receptors (34).”
From Coming Off Prescribed Psychotropic Medications: Insights from Their Use as Recreational Drugs (2020) · cites this paper as [34]
In the citing paper
“From the EMA database, 18,112 (8.64% of 209,571) and 4,178 (7.58% of 55,100) ADR reports of misuse/abuse/dependence and withdrawal were associated with quetiapine and olanzapine, respectively.”
From Coming Off Prescribed Psychotropic Medications: Insights from Their Use as Recreational Drugs (2020) · cites this paper as [34]
In the citing paper
“In the UK, Corkery et al (34) described 159 GHB/GBL-associated fatalities; most (79%) were accidental and GHB/GBL alone was implicated in 37% of cases.”
From Coming Off Prescribed Psychotropic Medications: Insights from Their Use as Recreational Drugs (2020) · cites this paper as [34]
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Abrams, P., Cardozo, L., Fall, M., Griffiths, D., Rosier, P., Ulmsten, U., van Kerrebroeck, P., Victor, A., & Wein, A. (2002) · Neurourology and Urodynamics · doi:10.1002/nau.10052 · Cited by 8,296
editor-in-chief, A. J. W. (2012) · Elsevier eBooks · Cited by 2,682
Ketamine-Associated Ulcerative Cystitis: A New Clinical Entity
Shahani, R., Streutker, C., Dickson, B., & Stewart, R. J. (2007) · Urology · doi:10.1016/j.urology.2007.01.038 · Cited by 373
The destruction of the lower urinary tract by ketamine abuse: a new syndrome?
Chu, P. S., Ma, W., Wong, S. C., Chu, R. W., Cheng, C., Wong, S., Tse, J. M., Lau, F., Yiu, M., & Man, C. (2008) · BJU International · doi:10.1111/j.1464-410x.2008.07920.x · Cited by 368
The prevalence and natural history of urinary symptoms among recreational ketamine users
Winstock, A. R., Mitcheson, L., Gillatt, D. A., & Cottrell, A. M. (2012) · BJU International · doi:10.1111/j.1464-410x.2012.11028.x · Cited by 214
Ketamine‐associated bladder dysfunction
Tsai, T., Cha, T., Lin, C., Tsao, C., Tang, S., Chuang, F., Wu, S., Sun, G., Yu, D., & Chang, S. (2009) · International Journal of Urology · doi:10.1111/j.1442-2042.2009.02361.x · Cited by 161
Mice are prone to kidney pathology after prolonged ketamine addiction
Yeung, L. Y., Rudd, J. A., Lam, W. P., Mak, Y. T., & Yew, D. T. W. (2009) · Toxicology Letters · doi:10.1016/j.toxlet.2009.09.006 · Cited by 84
Lee, C., Jiang, Y., & Kuo, H. (2013) · BJU International · doi:10.1111/bju.12256 · Cited by 82
Shao, Y., Shen, Z., Rui, W., & Zhou, W.-L. (2009) · Urology · doi:10.1016/j.urology.2009.09.078 · Cited by 77
Involvement of Purinergic Neurotransmission in Ketamine Induced Bladder Dysfunction
Meng, E., Chang, H.-Y., Chang, S.-Y., Sun, G.-H., Yu, D.-S., & Cha, T.-L. (2011) · Journal of Urology · doi:10.1016/j.juro.2011.04.102 · Cited by 76
Chuang, S., Liu, K., Li, Y., Jang, M., Lee, H., Wu, W., Chang, W., Levin, R. M., & Juan, Y. (2013) · Neurourology and Urodynamics · doi:10.1002/nau.22367 · Cited by 75
Tam, Y., Ng, C., Pang, K. K., Yee, C., Chu, W. C., Leung, V. Y., Wong, G. L., Wong, V. W., Chan, H. L., & Lai, P. B. (2014) · BJU International · doi:10.1111/bju.12675 · Cited by 54
Evaluation of the extent of ketamine-induced uropathy: the role of CT urography
Huang, L.-K., Wang, J.-H., Shen, S.-H., Lin, A. T. L., & Chang, C.-Y. (2014) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2013-131776 · Cited by 54
Self-citationElevated Serum IgE May be Associated with Development of Ketamine Cystitis
Jhang, J.-F., Hsu, Y.-H., Jiang, Y.-H., & Kuo, H.-C. (2014) · Journal of Urology · doi:10.1016/j.juro.2014.05.084 · Cited by 52
Augmentation enterocystoplasty is effective in relieving refractory ketamine‐related bladder pain
Chung, S., Wang, C., & Kuo, H. (2014) · Neurourology and Urodynamics · doi:10.1002/nau.22477 · Cited by 43
Ng, C., Chiu, P. K., Li, M.-L., Man, C., Hou, S. S. M., Chan, E., & Chu, P. S.-K. (2013) · International Urology and Nephrology · doi:10.1007/s11255-013-0501-4 · Cited by 42
Hills, C. E., Jin, T., Siamantouras, E., Liu, I. K.-K., Jefferson, K. P., & Squires, P. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071819 · Cited by 41
Bladder Pain Syndrome (Interstitial Cystitis) and Related Disorders
Hanno, P. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00012-8 · Cited by 34
Ketamine uropathy: rising to the challenges of a new condition
Forster, J. A., & Harrison, S. C. W. (2012) · British Journal of Urology · doi:10.1111/j.1464-410x.2012.10988.x · Cited by 14
Ketamine associated cystitis – A case report
Hoskins, R. (2008) · International Emergency Nursing · doi:10.1016/j.ienj.2008.09.002 · Cited by 14
[Imaging features of urinary dysfunction associated with ketamine abuse].
Wu, P., Zhao, J., Gao, L., Wang, Y., Zheng, H., Huang, Z., Gu, D., Huang, J., & Zheng, S. (2012) · PubMed · Cited by 2
Self-citation
Research works printed but not linked: 1
- Chiang I, Chang S, Yang S, Hsieh C (2010) Ketamine abuse associated with vesicoureteral reflux. Incont Pelvic Floor Dysfunct 4:57–58
Cited by
What urologists need to know about ketamine‐induced uropathy: A systematic review
Castellani, D., Pirola, G. M., Gubbiotti, M., Rubilotta, E., Gudaru, K., Gregori, A., & Dellabella, M. (2020) · Neurourology and Urodynamics · doi:10.1002/nau.24341 · Cited by 77
Smith-Apeldoorn, S. Y., Veraart, J. K. E., Kamphuis, J., van Asselt, A. D. I., Touw, D. J., aan het Rot, M., & Schoevers, R. A. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2359-1 · Cited by 39
Oral Ketamine in Treatment-Resistant Depression: A Clinical Effectiveness Case Series
Al Shirawi, M. I., Kennedy, S. H., Ho, K. T., Byrne, R., & Downar, J. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000717 · Cited by 37
Belal, M., Downey, A., Doherty, R., Ali, A., Hashim, H., Kozan, A., Kujawa, M., Pakzad, M. H., Rashid, T. G., Osman, N. I., et al. (2024) · British Journal of Urology · doi:10.1111/bju.16404 · Cited by 35
“Adapting and modifying a staging system from Wu et al. [17] (Table 2”
Myers, F. A., Bluth, M. H., & Cheung, W. W. (2016) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2016.07.008 · Cited by 32
Metadata
- Authors
- Wu, P., Wang, Q., Huang, Z., Wang, J., Wu, Q., & Lin, T.
- Affiliations
- Nanfang Hospital (CN)
- Sun Yat-sen University (CN)
- Corresponding author
- Wu, Peng
- Lin, Tianxin
- Venue
- World Journal of Urology
- Published
- 2016-01-23
- Volume
- 34
- Issue
- 9
- Pages
- 1329-1336
- ISSN
- 0724-4983 (ISSN-L)
- 1433-8726
- OpenAlex
- W2293806105
- Cited by
- 28
- References
- 23
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 4 · 2023: 2 · 2022: 5 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 2
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- World Journal of Urology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Natural Science Foundation of Guangdong Province,China (C1040037)
- Science and Technology Planning Project of Guangdong Province,China (20140212673)
- Topics
- Health Sciences › Medicine › Urology › Urinary Bladder and Prostate Research
- Health Sciences › Medicine › Urology › Urinary Tract Infections Management
- Health Sciences › Medicine › Urology › Urological Disorders and Treatments
- Keywords
- ketamine abuse, clinical staging, lower urinary tract symptoms, hydronephrosis, hydrodistention, behavior change, pharmacotherapy, surgical treatment, voiding dysfunction
- MeSH terms
- Female, Humans, Ketamine, Male, Retrospective Studies, Severity of Illness Index, Urologic Diseases, Disease Progression, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.